期刊文献+

中性粒细胞和淋巴细胞比值与银屑病的相关性研究 被引量:8

Correlation between neutrophil-to-lymphocyte ratio and psoriasis
下载PDF
导出
摘要 目的探讨中性粒细胞和淋巴细胞比值(NLR)与银屑病患者病情严重程度、分型、预后等相关性。方法回顾性分析148例银屑病患者中性粒细胞计数、淋巴细胞计数、C-反应蛋白(CRP)等血液学指标,计算NLR,比较分析NLR与CRP相关性,比较不同严重程度、不同类型的银屑病患者NLR水平,并将银屑病患者分为伴有代谢综合征(MS)组和不伴有MS组,比较两组NLR水平的差异。结果银屑病患者NLR与CRP水平具有相关性,重度银屑病患者NLR水平升高,红皮病性银屑病患者的NLR显著高于其他类型银屑病。并发MS的银屑病患者NLR水平高于未并发MS的银屑病患者,差异具有统计学意义。结论NLR水平升高的银屑病患者病情更重,特别是对并发MS的银屑病患者的病情判断及预后具有重要意义。 Objective To evaluate the relationship between neutrophil-to-lymphocyte ratio(NLR)and the severity,classification,prognosis of patients with psoriasis.Methods A total of 148 patients with psoriasis were measured for their hematological parameters including neutrophil counts,lymphocyte counts,C-reactive protein(CRP),and then NLR was calculated,furtherly the correlation between NLR and CRP,and the level of NLR in different severity and types of psoriasis patients were analyzed.Finally,the patients were divided into metabolic syndrome(MS)group and without metabolic syndrome group,and the diflference in NLR between the two groups was evaluated.Results NLR was positively correlated with CRP level,which was significantly elevated in patients with severe psoriasis.NLR was higher in patients with psoriasis erythrodermia than the other types.Psoriasis patients with MS were more likely to take on an increasing NLR than patients without MS.Conclusion NLR evidently increased in patients with psoriasis.NLR can be used to reflect the severity and prognosis of paoriasis patients,especially for those with MS.
作者 宋翠豪 王睿 赵梓纲 郑力强 丁香玉 张钧芬 李承新 SONG Cui-hao;WANG Rui;ZHAO Zi-gang(Department of Dermatology,Chinese PLA General Hospital,Beijing 100853,China)
出处 《实用皮肤病学杂志》 2019年第5期267-268,272,共3页 Journal of Practical Dermatology
基金 国家自然科学基金资助项目(81572680)
关键词 银屑病 中性粒细胞和淋巴细胞比值 代谢综合征 Psoriasis Neutrophil-to-lymphocyte ratio Metabolic syndrome
  • 相关文献

参考文献4

二级参考文献54

  • 1宋秀霞 ,纪立农 .国际糖尿病联盟代谢综合征全球共识定义[J].中华糖尿病杂志(1006-6187),2005,13(3):178-180. 被引量:610
  • 2Nesto RW. The relation of insulin resistance syndromes to risk of cardiovascular disease. Rev Cardiovasc Med,2003,4(suppl 6):s11-s18.
  • 3Pouliot MC, Després JP, Lemieux S, et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol,1994,73:460-468.
  • 4Brunzell JD, Ayyobi AF. Dyslipidemia in the metabolic syndrome and type 2 diabetes mellitus. Am J Med,2003,115(suppl 8A):24s-28s.
  • 5Robins SJ, Rubins HB, Faas FH, et al. Insulin resistance and cardiovascular events with low HDL cholesterol. The Veterans Affairs HDL Intervention Trial (VA-HIT). Diabetes Care,2003,26:1513-1517.
  • 6Steinmetz A, Fenselau S, Schrezenmeir J. Treatment of dyslipoproteinemia in the metabolic syndrome. Exp Clin Endocrinol Diabetes,2001,109:s548-559.
  • 7Robins SJ, Collins D, Wittes JT, et al. Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial. JAMA, 2001,285:1585-1591.
  • 8Tan CE, Ma S, Wai D, et al. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care, 2004,27:1182-1186.
  • 9Lindstrom J, Louheranta A, Mannelin M. The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care, 2003,26:3230-3236.
  • 10Tuomilehto J, Lindstrm J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. NEJM, 2001,344:1343-1350.

共引文献630

同被引文献117

引证文献8

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部